Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Rapt Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.70
20.02.24
€10.00
20.02.25
32.09%
21.02.24

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Newmont Corp.

Start price
Target price
Perf. (%)
€30.60
20.02.24
€33.00
20.02.25
3.92%
07.03.24

Standard Investments for future growth
Capable Management
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Clearmind Medicine Inc.

Start price
Target price
Perf. (%)
€1.88
20.02.24
-
20.02.25
-27.93%
02.03.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€1.15
20.02.24
-
20.02.25
-23.14%
02.03.24

Could be very worthwhile Investment >20% year
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€3.02
19.02.24
-
19.02.25
-44.15%
20.02.24

Probably not worthwhile Investment
buy
Ynvisible Interactive

Start price
Target price
Perf. (%)
€0.046
19.02.24
-
19.03.24
-1.30%
20.03.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Green Hydrogen Systems A/s

Start price
Target price
Perf. (%)
€0.10
19.02.24
€0.67
19.02.25
-
02.03.24

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Black Swan Graphene Inc.

Start price
Target price
Perf. (%)
€0.069
19.02.24
€0.035
19.02.25
-10.87%
02.03.24

Revenue growth >5% per year expected
Risky Investment
EBIT decline/stagnation expected
buy
Wimi Hologram Cloud Inc.

Start price
Target price
Perf. (%)
€1.13
19.02.24
-
19.02.25
-15.93%
02.03.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€2.42
19.02.24
€2.00
19.02.25
-37.87%
14.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€2.10
19.02.24
-
19.02.25
-10.26%
20.02.24

Risky Investment
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
Equillium Inc.

Start price
Target price
Perf. (%)
€2.69
19.02.24
-
19.02.25
-27.60%
02.04.24

Risky Investment
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
buy
Achilles Therapeutics Plc

Start price
Target price
Perf. (%)
€0.97
18.02.24
€2.00
31.01.26
0.52%
17.03.24

Could be very worthwhile Investment >20% year
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€2.69
17.02.24
€4.00
30.09.25
-18.44%
03.03.24

Could be very worthwhile Investment >20% year
buy
Azelis Group N.v.

Start price
Target price
Perf. (%)
€18.77
17.02.24
-
17.02.25
5.22%
02.03.24

Could be worthwhile Investment >10% per year
buy
Adevinta Asa

Start price
Target price
Perf. (%)
€10.03
17.02.24
-
17.02.25
-1.45%
02.03.24

Could be worthwhile Investment >10% per year
buy
Metavisio (thomson Computing)

Start price
Target price
Perf. (%)
€1.22
17.02.24
-
17.02.25
-19.34%
02.03.24

Could be worthwhile Investment >10% per year
buy
Intel Corp.

Start price
Target price
Perf. (%)
€16.90
17.02.24
€18.00
17.02.25
3.55%
07.03.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Fusion Fuel Green Plc

Start price
Target price
Perf. (%)
€2.76
16.02.24
-
16.02.25
-28.62%
17.02.24

Risky Investment
Fusion Fuel Green Plc

Start price
Target price
Perf. (%)
€2.21
16.02.24
-
16.02.25
-10.66%
17.02.24

Risky Investment
buy
Newmont Corp.

Start price
Target price
Perf. (%)
€30.60
15.02.24
€32.00
15.02.25
0.00%
20.02.24

Standard Investments for future growth
Capable Management
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Solutiance AG

Start price
Target price
Perf. (%)
€2.04
15.02.24
-
15.02.25
5.88%
25.04.24

buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.92
15.02.24
€2.00
15.02.25
25.91%
19.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected